Press releases

29.07.2010 - Shionogi Inc. Announces FDA approval of cuvposa for the treatment of chronic severe drooling in paediatric patients with neurologic conditions

29 Jul 2010
Sitemap
© Shionogi B.V. 2019. All rights reserved. This website is owned by Shionogi B.V. Registered with the Trade Register of the Dutch Chamber of Commerce under number 73229180. Registered address is Kingsfordweg 151, 1043GR, Amsterdam, the Netherlands.
Contact Us Report Side Effect Terms of use Privacy Policy Cookie Policy References
This website uses cookies to provide you with the best experience when you visit. By using this website, you consent to our use of these cookies. You can learn more about how we use cookies and how to manage them by reading our Cookie Policy
Cookie Policy
Just to let you know, you are now moving to another website this is not under our control and Shionogi B.V. is not responsible for its contents.
Continue
Go Back